Compare Endeavour Silver Corp (EXK) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Endeavour Silver Corp vs Recursion Pharmaceuticals Inc — how do they compare? Endeavour Silver Corp trades at $10.84 (market cap $3.14B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Endeavour Silver Corp is the larger of the two by market cap, and Endeavour Silver Corp is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| EXK | RXRX | |
|---|---|---|
Market Cap | $3.14B | $1.81B |
Sector | Basic Materials | Health |
52-Week High | $14.12 | $6.79 |
52-Week Low | $5.31 | $2.84 |
Enterprise Value | $3.14B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Endeavour Silver Corp
Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.
Read more on EXK →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
